ATE232728T1 - Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen - Google Patents

Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen

Info

Publication number
ATE232728T1
ATE232728T1 AT99937874T AT99937874T ATE232728T1 AT E232728 T1 ATE232728 T1 AT E232728T1 AT 99937874 T AT99937874 T AT 99937874T AT 99937874 T AT99937874 T AT 99937874T AT E232728 T1 ATE232728 T1 AT E232728T1
Authority
AT
Austria
Prior art keywords
axetil
pharmaceutical compositions
compositions containing
present
stable pharmaceutical
Prior art date
Application number
AT99937874T
Other languages
English (en)
Inventor
J K Chung
H H Kim
Joongwon-Ku
S H Lim
Soojeong-Ku Dong
Jeong Hwa Park
J W Park
Original Assignee
Dae Woong Pharma
Daewoong Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019980033463A external-priority patent/KR100299356B1/ko
Application filed by Dae Woong Pharma, Daewoong Chemical Co Ltd filed Critical Dae Woong Pharma
Application granted granted Critical
Publication of ATE232728T1 publication Critical patent/ATE232728T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99937874T 1998-03-03 1999-03-03 Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen ATE232728T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19980006866 1998-03-03
KR1019980033463A KR100299356B1 (ko) 1998-03-03 1998-08-18 수분흡수에대해안정한세푸록심악세틸함유제약조성물
PCT/KR1999/000095 WO1999044614A1 (en) 1998-03-03 1999-03-03 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption

Publications (1)

Publication Number Publication Date
ATE232728T1 true ATE232728T1 (de) 2003-03-15

Family

ID=26633486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99937874T ATE232728T1 (de) 1998-03-03 1999-03-03 Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen

Country Status (7)

Country Link
EP (1) EP1066040B1 (de)
JP (1) JP2002505290A (de)
AT (1) ATE232728T1 (de)
AU (1) AU3277899A (de)
CA (1) CA2322432C (de)
DE (1) DE69905452D1 (de)
WO (1) WO1999044614A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
AU2001278673A1 (en) * 2000-10-30 2002-05-15 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
JP4617069B2 (ja) * 2003-06-16 2011-01-19 コスメディ製薬株式会社 貼付剤
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
JP2005239696A (ja) * 2004-01-30 2005-09-08 Daiichi Suntory Pharma Co Ltd 無機物質を配合した医薬硬質カプセル剤
EP2566458B1 (de) * 2010-05-04 2015-08-05 Mahmut Bilgic Pharmazeutische formulierungen mit cefuroxim-axetil
TR201103625A1 (tr) 2011-04-14 2012-12-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Sefuroksim içeren tablet formülasyonu üretim prosesi.
WO2013100880A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Formulations comprising cefuroxime
US9687453B2 (en) 2013-04-25 2017-06-27 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP2990038B1 (de) 2013-04-25 2019-11-20 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
CN105456208A (zh) * 2014-09-05 2016-04-06 深圳信立泰药业股份有限公司 一种头孢呋辛酯药物组合物及其制备方法
EP3210608A4 (de) * 2014-10-23 2018-06-20 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
EP3210607A4 (de) 2014-10-23 2018-06-06 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
CN104666258B (zh) * 2014-12-23 2017-08-25 北京京丰制药集团有限公司 一种头孢呋辛酯片剂组合物及其制备方法
CN113952313A (zh) * 2021-08-26 2022-01-21 宁夏医科大学 一种头孢呋辛酯胶囊及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations

Also Published As

Publication number Publication date
AU3277899A (en) 1999-09-20
CA2322432A1 (en) 1999-09-10
WO1999044614A1 (en) 1999-09-10
JP2002505290A (ja) 2002-02-19
CA2322432C (en) 2005-12-20
EP1066040A1 (de) 2001-01-10
EP1066040B1 (de) 2003-02-19
DE69905452D1 (de) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE232728T1 (de) Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
TWI235068B (en) Sustained-release pharmaceutical composition
IS4326A (is) Ný forðakyrni og lyfjablanda sem inniheldur þau
SI1578422T1 (sl) Fizikalno in kemiäśno stabilni nikotin in mikrokristal na celulozo vsebujoäś material iz trdnih delcev
AU2001236497A1 (en) Anhydrous antiperspirant compositions containing water-reactive monomers as antiperspirant active
WO2001032646A3 (en) Sulfonamide derivatives
HUP0201011A3 (en) Aminopyrimidines as sorbitol dehydrogenase inhibitors and pharmaceutical compositions containing them
IS1940B (is) Lyfjasamsetningar sem innihalda HMG afoxunarensímlata
CA2463947A1 (en) Montelukast granule formulation
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
PT938316E (pt) Formulacao galenica contendo antagonistas de opioides
HU9402077D0 (en) Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptrable salts of gamma hydroxy-butyric acid
CA2433585A1 (en) Pharmaceutical compositions containing donepezil hydrochloride
GEP20094676B (en) Piperidine compounds and pharmaceutical compositions containing them
DK1608362T3 (da) Stabiliseret farmaceutisk præparat indeholdende en amorf aktiv forbindelse
PL352529A1 (en) Amorphous esters of nitric acid and pharmaceutical composities containing them
SE0102843D0 (sv) Stabilized oral pharmaceutical composition containing lodide and lodate and method
HUP0103431A3 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
MY129564A (en) Compositions comprising cefuroxime axetil
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
HUP0301919A2 (hu) Szabályozott pH tartományban levż stabil gabapentin
IL123185A0 (en) Stable solid formulation of enalapril salt and process for preparation thereof
DK1142573T3 (da) Farmaceutiske præparater omfattende faropenem-natrium og en diaminacetatforbindelse til forbedring af absorption i mave-tarm-kanalen
HUP0200213A2 (en) Alkynyl containing hydroxamic acid compounds as tace inhibitors, process for their preparation and pharmaceutical compositions containing them
CA2268399A1 (en) Anti-neurogenic inflammatory compounds and compositions and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties